NCT05364983: An ongoing trial by LensGen, Inc.
This trial is ongoing. It must report results 4 weeks, 1 day from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05364983 |
|---|---|
| Title | A Prospective, Randomized, Controlled, Double-Masked, Phased, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of the LensGen® Juvene® Intraocular Lens |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 31, 2023 |
| Completion date | Nov. 30, 2024 |
| Required reporting date | Nov. 30, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Oct. 31, 2025 |
| Days late | None |